🔎 Trials Near Me

Utama › Kanser Payudara › Wilayah Columbia

Kajian klinikal Kanser Payudara di Wilayah Columbia

28 kajian untuk Kanser Payudara sedang mencari peserta di lokasi di Wilayah Columbia.

Bandar di Wilayah Columbia

Teks kajian rasmi (Bahasa Inggeris)

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

  • Georgetown University Medical Center, Washington D.C.
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 5 Okt 2026 · NCT06982521

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

  • Georgetown University Lombardi Cancer Center, Washington D.C.
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05827081

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

Older Breast Cancer Patients: Risk for Cognitive Decline

  • Georgetown University, Washington D.C.
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 60 hingga 105 · Wanita · Dikemas kini 28 Sep 2026 · NCT03451383

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

  • The George Washington Medical facility Associates, Washington D.C.
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07007559

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • MedStar Washington Hospital Center, Washington D.C.
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07174336

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

  • Georgetown Uni Hospital, Washington D.C.
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05894239

Identifying Patterns in the Breath of Individuals With Breast Cancer

  • GW Comprehensive Breast Center, Washington D.C.
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 40 hingga 74 · Wanita · Dikemas kini 18 Sep 2026 · NCT06512350

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

  • Georgetown University Medical Center, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • Sibley Memorial Hospital, Washington D.C.
  • dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT06492616

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer

  • MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center, Washington D.C.
Mengambil pesertaFasa 1
Umur 18 hingga 55 · Wanita · Dikemas kini 9 Sep 2026 · NCT07310420

Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration

  • Georgetown University, Washington D.C.
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT05315700

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • dan 2 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 60 · Wanita · Dikemas kini 2 Sep 2026 · NCT05879926

TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

  • Georgetown University Medical Center, Washington D.C.
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06533826

Gut Microbiome, Adverse Effects, and Markers Through MEtabolic Reprogramming

  • Sibley Memorial Hospital, Washington D.C.
Mengambil peserta
Umur 18 ke atas · Wanita · Dikemas kini 21 Ogo 2026 · NCT06536881

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

  • Sibley Memorial Hospital, Washington D.C.
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT06500481

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

  • Johns Hopkins Medicine - Kimmel Cancer Center-Sibley Memorial Hospital, Washington D.C.
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT05232916

E-Mindfulness Approaches for Living After Breast Cancer

  • Kaiser Permanente-Capitol Hill Medical Center, Washington D.C.
  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
Mengambil pesertaFasa 3
Umur 18 hingga 50 · Semua jantina · Dikemas kini 4 Ogo 2026 · NCT06748222

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

  • Georgetown University Medical Center, Washington D.C.
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT01042379

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

  • MedStar Washington Hospital Center, Washington D.C.
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT07062965

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

  • MedStar Georgetown University Hospital, Washington D.C.
  • MedStar Washington Hospital Center, Washington D.C.
  • George Washington University Medical Center, Washington D.C.
Mengambil pesertaFasa 3
Umur 50 hingga 70 · Semua jantina · Dikemas kini 23 Apr 2026 · NCT04852887

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

  • Cancer Support Community Research & Training Institute, Washington D.C.
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Apr 2026 · NCT02333604

Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer

  • Georgetown University, Washington D.C.
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Apr 2026 · NCT04841148

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

  • George Washington-Medical Faculty Associates, Washington D.C.
Mengambil pesertaFasa 2
Umur 21 ke atas · Semua jantina · Dikemas kini 3 Mac 2026 · NCT06806930

The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer

  • Sibley Memorial Hospital, Washington D.C.
Mengambil peserta
Umur 18 ke atas · Wanita · Dikemas kini 23 Feb 2026 · NCT05780814

Study in Patients With Breast Cancer Leptomeningeal Metastasis

  • Sibley Memorial Hospital, Washington D.C.
Mengambil pesertaKajian pemerhatian
18 Weeks · Semua jantina · Dikemas kini 28 Nov 2025 · NCT06638294

The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

  • Georgetown University, Washington D.C.
Mengambil peserta
Umur 18 hingga 74 · Wanita · Dikemas kini 30 Sep 2025 · NCT06892275

CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

  • Georgetown Lombardi Comprehensive Cancer Center, Washington D.C.
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Wanita · Dikemas kini 28 Ogo 2025 · NCT05130606

CtDNA Based MRD Testing for NAC Monitoring in TNBC

  • George Washington University, Washington D.C.
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Wanita · Dikemas kini 7 Jan 2025 · NCT06230185

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.